Alzheimer’s risk may be 35% lower with common menopause treatment, study finds
While the study findings don’t change current clinical recommendations, Hosseini said they highlight the need for well-designed clinical trials to confirm these observations and to determine whether menopausal hormone therapy has a protective cognitive effect.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
“These results add meaningful, first-of-their-kind pathological evidence to a genuinely controversial area — but they are a signal for further study, not a reason to start or stop MHT for brain health,” Bruno added.
“We need prospective, biomarker-based trials that follow women before, during and after menopause to understand the effects of MHT on brain health.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
The study was funded by the National Institutes of Health.
Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
Article source: https://www.foxnews.com/health/alzheimers-risk-35-percent-lower-common-menopause-treatment-study-finds